MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Pack size 
EU/1/10/614/002 
Menveo   
--ยน 
Powder and solution 
for solution for 
injection 
Intramuscular use 
EU/1/10/614/003 
Menveo   
--ยน 
Powder and solution 
for solution for 
injection 
Intramuscular use 
EU/1/10/614/004 
Menveo   
--ยน 
Powder and solution 
for solution for 
injection 
Intramuscular use 
5 vials + 5 vials 
1 vial + 1 vial 
10 vials + 10 vials 
MenA lyophilised 
conjugate component: 
vial (glass); MenCWY 
liquid conjugate 
component: vial 
(glass) 
MenA lyophilised 
conjugate component: 
vial (glass); MenCWY 
liquid conjugate 
component: vial 
(glass) 
MenA lyophilised 
conjugate component: 
vial (glass); MenCWY 
liquid conjugate 
component: vial 
(glass) 
--ยน  Meningococcal group A oligosaccharide 10 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 16.7 to 33.3 micrograms/0.5 ml 
Meningococcal group C oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 7.1 to 12.5 micrograms/0.5 ml 
Meningococcal group W135 oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 3.3 to 8.3 micrograms/0.5 ml 
Meningococcal group Y oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 5.6 to 10.0 micrograms/0.5 ml 
 
 
 
 
 
 
